European regulator ‘convinced’ benefits of AstraZeneca vaccine outweigh risks as suspensions continue
Europe’s medicines regulator has said there’s “no indication” that the Oxford-AstraZeneca Covid-19 vaccine has caused blood clots, as the list of countries temporarily halting the vaccine’s rollout over safety concerns continues to grow. On Tuesday, Cyprus, Luxembourg, Latvia and Sweden became the latest European nations to suspend its use, despite advice from the European Medical
Continue Reading